Physician profile
Amer Rasheed
NPI 1417454778
$4,668.96
in general payments reported to CMS, 2019-2025
9 companies · $400 in 2025
The $400 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $543 · 2022: $563 · 2023: $745 · 2024: $2,418 · 2025: $400.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,822 · Travel and Lodging: $1,379 · Education: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,822.25 |
| Travel and Lodging | $1,378.77 |
| Education | $361.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,217.23 | 2024-2025 | Indigo System, Ruby Coil |
| Medtronic, INC. | $1,483.84 | 2021-2025 | Venaseal, Endurant Iis, Concertotm |
| Boston Scientific Corporation | $268.27 | 2023-2024 | Therasphere Y90 Glass Microspheres 10 Gbq, Therasphere Administration Set |
| Siemens Medical Solutions USA, INC. | $245.52 | 2025 | |
| Inari Medical, INC. | $233.22 | 2022-2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| W. L. Gore & Associates, INC. | $124.87 | 2024 | Gore Viabahn Endoprosthesis With Heparin |
| Terumo Medical Corporation | $64.30 | 2022-2023 | Azur Cx Detachable |
| Chiesi USA, INC. | $18.51 | 2024 | Kengreal, Cleviprex |
| Sirtex Medical INC | $13.20 | 2023 | Sir-Spheres Microspheres |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amer Rasheed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.